Literature DB >> 8583537

Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.

M J Mengelers1, E R Van Gogh, H A Kuiper, A Pijpers, J H Verheijden, A S Van Miert.   

Abstract

The pharmacokinetics of two sulfonamide/trimethoprim combinations were investigated after intravenous administration to clinically healthy pigs and to the same pigs following a challenge with Actinobacillus pleuropneumoniae toxins. Endobronchial challenge with A. pleuropneumoniae toxins resulted in fever, increased white blood cell counts and decreased water and feed consumption. Healthy, as well as febrile, pigs were given sulfadimethoxine (SDM) or sulfamethoxazole (SMX) intravenously at a dose of 25 mg/kg b.w. in combination with 5 mg trimethoprim (TMP) per kg body weight. The pharmacokinetic parameters of the sulfonamides as well as their main metabolites (acetyl sulfonamides) were not significantly different in healthy and febrile pigs. In healthy and pneumonic pigs, the mean elimination half-lives of SDM were 12.9 h and 13.4 h, respectively, those of SMX 2.5 h and 2.7 h, respectively, and those of TMP 2.8 h and 2.6 h, respectively. Distribution volumes in healthy and febrile pigs of SDM and SMX varied between 0.2 and 0.4 L/kg, and those of TMP between 1.1 and 1.6 L/kg. The mean AUC of TMP was decreased and the volume of distribution and total body clearance of TMP were increased in febrile pigs. Protein binding of the drugs and metabolites studied were not significantly changed after toxin-induced fever. The extent of protein binding of SDM, SMX and TMP was in the range 94-99%, 45-56% and 40-50%, respectively. Based on knowledge of in vitro antimicrobial activity of the drug combinations against A. pleuropneumoniae it was concluded that after intravenous administration of the dose administered (30 mg/kg of the combination preparations) to healthy and pneumonic pigs, plasma concentrations of SMX and TMP were above the concentration required for growth inhibition of 50% of A., pleuropneumoniae strains for approximately 16 h, whereas bacteriostatic plasma concentrations of SDM were still present after TMP had been eliminated from plasma. Because of similar elimination half-lives of SMX and TMP in pigs this combination is preferred to the combination of SDM with TMP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8583537     DOI: 10.1111/j.1365-2885.1995.tb00588.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  3 in total

1.  Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after oral single- and multiple-dose administration to healthy pigs.

Authors:  M J Mengelers; E R van Gogh; M B Huveneers; P E Hougee; H A Kuiper; A Pijpers; J H Verheijden; A S van Miert
Journal:  Vet Res Commun       Date:  2001-08       Impact factor: 2.459

2.  Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.

Authors:  Eric Ouattara; Christine Danel; Raoul Moh; Delphine Gabillard; Gilles Peytavin; Romuald Konan; Jérome Le Carrou; Franck Bohoussou; Serge P Eholie; Xavier Anglaret
Journal:  J Int AIDS Soc       Date:  2013-04-30       Impact factor: 5.396

3.  Antibacterial Residue Excretion via Urine as an Indicator for Therapeutical Treatment Choice and Farm Waste Treatment.

Authors:  María Jesús Serrano; Diego García-Gonzalo; Eunate Abilleira; Janire Elorduy; Olga Mitjana; María Victoria Falceto; Alicia Laborda; Cristina Bonastre; Luis Mata; Santiago Condón; Rafael Pagán
Journal:  Antibiotics (Basel)       Date:  2021-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.